Glucocorticoid regulation of cancer development and progression

Bibliographic Details
Title: Glucocorticoid regulation of cancer development and progression
Authors: Stuti Khadka, Sara R. Druffner, Benjamin C. Duncan, Jonathan T. Busada
Source: Frontiers in Endocrinology, Vol 14 (2023)
Publisher Information: Frontiers Media S.A., 2023.
Publication Year: 2023
Collection: LCC:Diseases of the endocrine glands. Clinical endocrinology
Subject Terms: glucocorticoids, inflammation, steroid hormones, cancer development, corticosteroids, endocrine, Diseases of the endocrine glands. Clinical endocrinology, RC648-665
More Details: Glucocorticoids are steroid hormones that regulate a host of cellular and physiological functions. However, they are arguably best known for their potent anti-inflammatory properties. Chronic inflammation is well-known to promote the development and progression of numerous types of cancer, and emerging evidence suggests that glucocorticoid regulation of inflammation affects cancer development. However, the timing, intensity, and duration of glucocorticoid signaling have important but often contradictory effects on cancer development. Moreover, glucocorticoids are widely used in parallel with radiation and chemotherapy to control pain, dyspnea, and swelling, but their use may compromise anti-tumor immunity. This review will explore the effects of glucocorticoids on cancer development and progression with particular focus on pro and anti-tumor immunity.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-2392
Relation: https://www.frontiersin.org/articles/10.3389/fendo.2023.1161768/full; https://doaj.org/toc/1664-2392
DOI: 10.3389/fendo.2023.1161768
Access URL: https://doaj.org/article/5f685bf916e444d3bf7a0eb7a99227de
Accession Number: edsdoj.5f685bf916e444d3bf7a0eb7a99227de
Database: Directory of Open Access Journals
More Details
ISSN:16642392
DOI:10.3389/fendo.2023.1161768
Published in:Frontiers in Endocrinology
Language:English